Grifols is a global healthcare company that since 1909 has enhanced the health and well-being of people around the world. Four divisions - Bioscience, Diagnostic, Hospital and Bio Supplies - develop, produce and market innovative solutions and services in more than 100 countries. As pioneers in the field of the plasma science, they are one of the largest plasma companies with a growing network of donation centers worldwide. Grifols develops this plasma into essential medicines used to treat rare, chronic and, at times, life-threatening conditions. As a recognized leader in transfusion medicine, they also offer a comprehensive portfolio of solutions designed to enhance safety from donation through transfusion. They continue to advance our legacy of innovation by supplying tools, information and services that enable hospitals, pharmacies and healthcare professionals to efficiently deliver expert medical care. Grifols, with more than 24,000 employees in 30 countries and regions, is committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry. It's an Industry leader in producing plasma-derived medicines and transfusion medicine for patients around the world. Grifols sells its products and services in more than 100 countries and have subsidiaries in 30 of them. They aim to be a global leader in their markets, and they continue to be an industry reference for quality, safety and innovation.

Considering all above, if you were Marketing Manager of Grifols:

1) Which segmentation strategy should you define

2) Which distribution channels could be the most adequate

3) Which communication strategy should you help to increase your market penetration?